Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Myelodysplastic syndromes standardized response criteria: further definition.

Cheson BD, Bennett JM, Kantarjian H, Schiffer CA, Nimer SD, Löwenberg B, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Greenberg PL.

Blood. 2001 Sep 15;98(6):1985. No abstract available.

2.

[Risk-stratified treatment strategy for myelodysplastic syndromes].

Ichikawa M.

Rinsho Ketsueki. 2012 Oct;53(10):1509-15. Review. Japanese. No abstract available.

PMID:
23037723
3.

Classification, treatment goals, and management principles for myelodysplastic syndromes.

Gore S.

Cancer Control. 2004 Nov-Dec;11(6 Suppl):3-6. Review. No abstract available.

PMID:
15625530
4.

Myelodysplastic syndromes. Clinical practice guidelines in oncology.

National Comprehensive Cancer Network..

J Natl Compr Canc Netw. 2003 Oct;1(4):456-71. Review.

PMID:
19774738
5.

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.

Gattermann N.

Int J Hematol. 2008 Jul;88(1):24-9. doi: 10.1007/s12185-008-0118-z. Epub 2008 Jun 27. Review.

6.

Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.

Gattermann N.

Leuk Res. 2007 Dec;31 Suppl 3:S10-5. doi: 10.1016/S0145-2126(07)70461-7. Review.

PMID:
18037413
7.

Myelodysplastic syndromes: disease overview and therapy options.

Coutré S.

Manag Care. 2008 Jul;17(7 Suppl 6):3-8. Review.

8.

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.

Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, Loken M, van de Loosdrecht A, Ogata K, Orfao A, Pfeilstöcker M, Rüter B, Sperr WR, Stauder R, Wells DA.

Leuk Res. 2007 Jun;31(6):727-36. Epub 2007 Jan 25. Review.

PMID:
17257673
9.

[Guideline for the care of hematologic diseases based on EBM].

Kanamaru A.

Nihon Naika Gakkai Zasshi. 2007 Mar 10;96(3):475-82. Review. Japanese. No abstract available.

PMID:
17419413
10.

Response assessments in low-risk and high-risk myelodysplastic syndromes (MDS).

Fenaux P.

Semin Oncol. 2005 Aug;32(4 Suppl 5):S11-5. Review.

PMID:
16085012
11.

Methyltransferase inhibitors: changing the treatment algorithm for myelodysplastic syndromes.

List A.

Cancer Control. 2004 Nov-Dec;11(6 Suppl):16-9. Review. No abstract available.

12.

The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002).

Bennett JM, Kouides PA, Forman SJ.

Int J Hematol. 2002 Aug;76 Suppl 2:228-38. Review.

PMID:
12430930
13.

Iron overload in myelodysplastic syndromes: a Canadian consensus guideline.

Wells RA, Leber B, Buckstein R, Lipton JH, Hasegawa W, Grewal K, Yee K, Olney HJ, Larratt L, Vickars L, Tinmouth A.

Leuk Res. 2008 Sep;32(9):1338-53. doi: 10.1016/j.leukres.2008.02.021. Epub 2008 Apr 11.

PMID:
18405971
14.

Transplant strategies for patients with myelodysplastic syndromes.

Deeg HJ.

Curr Opin Hematol. 2006 Mar;13(2):61-6. Review.

PMID:
16456370
15.

An introduction to acute heart failure syndromes: definition and classification.

Filippatos G, Zannad F.

Heart Fail Rev. 2007 Jun;12(2):87-90. Review. No abstract available.

PMID:
17508282
16.

Treatment strategies in myelodysplastic syndromes.

Atallah E, Garcia-Manero G.

Cancer Invest. 2008 Mar;26(2):208-16. doi: 10.1080/07357900701788122. Review.

PMID:
18259954
17.

Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches.

Warlick ED, Smith BD.

Curr Cancer Drug Targets. 2007 Sep;7(6):541-58. Review.

PMID:
17896920
18.

[The strategy for the treatment of myelodysplastic syndromes].

Hideaki M.

Rinsho Ketsueki. 2002 Mar;43(3):157-60. Review. Japanese. No abstract available.

PMID:
11979745
19.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.

Oliansky DM, Antin JH, Bennett JM, Deeg HJ, Engelhardt C, Heptinstall KV, de Lima M, Gore SD, Potts RG, Silverman LR, Jones RB, McCarthy PL Jr, Hahn T.

Biol Blood Marrow Transplant. 2009 Feb;15(2):137-72. doi: 10.1016/j.bbmt.2008.12.003. Review. Erratum in: Biol Blood Marrow Transplant. 2009 May;15(5):650.

20.

Pediatric myelodysplastic syndromes.

Niemeyer CM, Kratz CP, Hasle H.

Curr Treat Options Oncol. 2005 May;6(3):209-14. Review.

PMID:
15869732

Supplemental Content

Support Center